194 related articles for article (PubMed ID: 20090779)
1. Biclonal origin prevails in concomitant chronic lymphocytic leukemia and multiple myeloma.
Pantic M; Schroettner P; Pfeifer D; Rawluk J; Denz U; Schmitt-Gräff A; Veelken H; Wäsch R; Engelhardt M
Leukemia; 2010 Apr; 24(4):885-90. PubMed ID: 20090779
[No Abstract] [Full Text] [Related]
2. Combined cytogenetic testing and fluorescence in situ hybridization analysis in the study of chronic lymphocytic leukemia and multiple myeloma.
Wiktor A; Van Dyke DL
Cancer Genet Cytogenet; 2004 Aug; 153(1):73-6. PubMed ID: 15325099
[TBL] [Abstract][Full Text] [Related]
3. Various patterns of IgH deletion identified by FISH using combined IgH and IgH/CCND1 probes in multiple myeloma and chronic lymphocytic leukemia.
Hwang Y; Lee JY; Mun YC; Seong CM; Chung WS; Huh J
Int J Lab Hematol; 2011 Jun; 33(3):299-304. PubMed ID: 21272268
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of clonal origin of concomitant chronic lymphocytic leukemia and multiple myeloma in a patient with advanced age].
Zhu P; Ma M; Yu J
Zhonghua Nei Ke Za Zhi; 1996 May; 35(5):326-8. PubMed ID: 9387618
[TBL] [Abstract][Full Text] [Related]
5. Absence of microsatellite instability in human chronic lymphocytic leukaemia B cells.
Praz F; Le Page F; Vallat L; Davi F; Nguyen-Khac F; Maloum K; Delic J; Merle-Béral H
Leukemia; 2008 Jan; 22(1):186-9. PubMed ID: 17673901
[No Abstract] [Full Text] [Related]
6. Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia.
Lehmann S; Ogawa S; Raynaud SD; Sanada M; Nannya Y; Ticchioni M; Bastard C; Kawamata N; Koeffler HP
Cancer; 2008 Mar; 112(6):1296-305. PubMed ID: 18246537
[TBL] [Abstract][Full Text] [Related]
7. Evolutionary sequence of cytogenetic aberrations during the oncogenesis of plasma cell disorders. Direct evidence at single cell level.
Nagy Z; Kajtár B; Jáksó P; Dávid M; Kosztolányi S; Hermesz J; Kereskai L; Pajor L; Alpár D
Leuk Res; 2011 Aug; 35(8):1114-6. PubMed ID: 21377730
[TBL] [Abstract][Full Text] [Related]
8. Genetics of chronic lymphocytic leukemia.
Schnaiter A; Mertens D; Stilgenbauer S
Clin Lab Med; 2011 Dec; 31(4):649-58, ix. PubMed ID: 22118742
[TBL] [Abstract][Full Text] [Related]
9. Unique gene expression and clinical characteristics are associated with the 11q23 deletion in chronic lymphocytic leukaemia.
Dickinson JD; Smith LM; Sanger WG; Zhou G; Townley P; Lynch JC; Pavletic ZS; Bierman PJ; Joshi SS
Br J Haematol; 2005 Feb; 128(4):460-71. PubMed ID: 15686453
[TBL] [Abstract][Full Text] [Related]
10. Differences in prognosis of stereotyped IGHV3-21 chronic lymphocytic leukaemia according to additional molecular and cytogenetic aberrations.
Jeromin S; Haferlach C; Dicker F; Alpermann T; Haferlach T; Kern W
Leukemia; 2016 Nov; 30(11):2251-2253. PubMed ID: 27411488
[No Abstract] [Full Text] [Related]
11. In multiple myeloma, circulating hyperdiploid B cells have clonotypic immunoglobulin heavy chain rearrangements and may mediate spread of disease.
Pilarski LM; Giannakopoulos NV; Szczepek AJ; Masellis AM; Mant MJ; Belch AR
Clin Cancer Res; 2000 Feb; 6(2):585-96. PubMed ID: 10690543
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
[TBL] [Abstract][Full Text] [Related]
13. The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells.
López-Corral L; Gutiérrez NC; Vidriales MB; Mateos MV; Rasillo A; García-Sanz R; Paiva B; San Miguel JF
Clin Cancer Res; 2011 Apr; 17(7):1692-700. PubMed ID: 21325290
[TBL] [Abstract][Full Text] [Related]
14. High-risk clonal evolution in chronic B-lymphocytic leukemia: single-center interphase fluorescence in situ hybridization study and review of the literature.
Janssens A; Van Roy N; Poppe B; Noens L; Philippé J; Speleman F; Offner F
Eur J Haematol; 2012 Jul; 89(1):72-80. PubMed ID: 22509718
[TBL] [Abstract][Full Text] [Related]
15. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
[TBL] [Abstract][Full Text] [Related]
16. Clonally rearranged antigen receptor gene DNA studies in evaluation of susceptibility of neoplastic lymphocytic and plasmacytic disorders to selective loss in long-term marrow culture.
Farag SS; Firkin FC
Leukemia; 1994 Aug; 8(8):1369-74. PubMed ID: 8057675
[TBL] [Abstract][Full Text] [Related]
17. Karyotype complexity and VH gene status in B-cell chronic lymphocytic leukemia.
Méhes G; Kovács G; Kajtár B; Lacza A; Várnai A; Losonczy H; Pajor L
Haematologica; 2006 Oct; 91(10):1430-1. PubMed ID: 16963400
[TBL] [Abstract][Full Text] [Related]
18. Chronic lymphocytic leukemia developing in a patient with chronic myeloid leukemia: evidence of distinct lineage-associated genomic events.
Gargallo P; Cacchione R; Chena C; Dupont J; Garay G; Riveros D; Larripa I; Slavutsky I
Cancer Genet Cytogenet; 2005 Aug; 161(1):74-7. PubMed ID: 16080961
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
[TBL] [Abstract][Full Text] [Related]
20. Identification of malignant cells in multiple myeloma bone marrow with immunoglobulin VH gene probes by fluorescent in situ hybridization and flow cytometry.
Cao J; Vescio RA; Hong CH; Kim A; Lichtenstein AK; Berenson JR
J Clin Invest; 1995 Mar; 95(3):964-72. PubMed ID: 7883997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]